Uzbekistan: Hundreds of Pharmacies Caught Inflating Drug Prices
Uzbekistan's State Committee on Competition has identified hundreds of pharmacies that illegally increased drug prices. These pharmacies exceeded the established retail markups for medicinal products, a violation that was discovered during investigations. The committee found that 237 pharmacies had unfairly generated revenue totaling 1.9 billion Uzbekistani Som. This action by the pharmacies occurred in the second quarter of 2026. The regulatory body's findings highlight a significant issue with price gouging in the pharmaceutical sector within the country. The investigation aimed to ensure fair pricing and protect consumers from unjustified cost increases.
The identified overpricing by 237 pharmacies in Uzbekistan, resulting in an estimated 1.9 billion Som in unjustified revenue, points to potential systemic weaknesses in pharmaceutical price regulation and enforcement. This situation may incentivize other market actors to exploit similar loopholes, particularly if penalties are perceived as insufficient deterrents. Looking ahead, robust oversight mechanisms and transparent pricing frameworks will be crucial to foster a competitive market that prioritizes patient access and affordability over opportunistic profit-taking, especially as healthcare demands evolve in the coming decade.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.